Clinical Trial Update: Open Pilot Trial of BHV-4157 [Phase 3]

View source ↗

Summary

The UCLA-sponsored open pilot Phase 3 trial of BHV-4157 for spinocerebellar ataxias and Multiple System Atrophy with cerebellar type (MSA-C) is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy-cerebellar Type
• Spinocerebellar Ataxia Type

Drugs mentioned

• BHV-4157

Snippet

Sponsor: University of California, Los Angeles | Conditions: Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1 | Phase 3 | Status: ACTIVE_NOT_RECRUITING